188 related articles for article (PubMed ID: 16450401)
21. Impact of histological subtype on survival of patients with surgically-treated stage IA2-IIB cervical cancer: adenocarcinoma versus squamous cell carcinoma.
Mabuchi S; Okazawa M; Matsuo K; Kawano M; Suzuki O; Miyatake T; Enomoto T; Kamiura S; Ogawa K; Kimura T
Gynecol Oncol; 2012 Oct; 127(1):114-20. PubMed ID: 22728518
[TBL] [Abstract][Full Text] [Related]
22. Systematic gene microarray analysis of the lncRNA expression profiles in human uterine cervix carcinoma.
Chen J; Fu Z; Ji C; Gu P; Xu P; Yu N; Kan Y; Wu X; Shen R; Shen Y
Biomed Pharmacother; 2015 May; 72():83-90. PubMed ID: 26054679
[TBL] [Abstract][Full Text] [Related]
23. STAT3:FOXM1 and MCT1 drive uterine cervix carcinoma fitness to a lactate-rich microenvironment.
Silva LS; Goncalves LG; Silva F; Domingues G; Maximo V; Ferreira J; Lam EW; Dias S; Felix A; Serpa J
Tumour Biol; 2016 Apr; 37(4):5385-95. PubMed ID: 26563366
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of insulin-like growth factor binding protein-5 (IGFBP-5): novel marker for cervical carcinogenesis.
Miyatake T; Ueda Y; Nakashima R; Yoshino K; Kimura T; Murata T; Nomura T; Fujita M; Buzard GS; Enomoto T
Int J Cancer; 2007 May; 120(10):2068-77. PubMed ID: 17290407
[TBL] [Abstract][Full Text] [Related]
25. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of Bmi-1 in uterine cervical cancer: correlation with clinicopathology and prognosis.
Zhang X; Wang CX; Zhu CB; Zhang J; Kan SF; Du LT; Li W; Wang LL; Wang S
Int J Gynecol Cancer; 2010 Dec; 20(9):1597-603. PubMed ID: 21370603
[TBL] [Abstract][Full Text] [Related]
27. Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma.
Hamamoto J; Soejima K; Yoda S; Naoki K; Nakayama S; Satomi R; Terai H; Ikemura S; Sato T; Yasuda H; Hayashi Y; Sakamoto M; Takebayashi T; Betsuyaku T
Mol Med Rep; 2013 Aug; 8(2):456-62. PubMed ID: 23759980
[TBL] [Abstract][Full Text] [Related]
28. Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy.
Chen JL; Huang CY; Huang YS; Chen RJ; Wang CW; Chen YH; Cheng JC; Cheng AL; Kuo SH
Acta Obstet Gynecol Scand; 2014 Jul; 93(7):661-8. PubMed ID: 24666257
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the prognostic significance of nm23/NDP kinase protein expression in cervical carcinoma: an immunohistochemical study.
Kristensen GB; Holm R; Abeler VM; Tropé CG
Gynecol Oncol; 1996 Jun; 61(3):378-83. PubMed ID: 8641619
[TBL] [Abstract][Full Text] [Related]
30. Identification of potential biomarkers of lymph node metastasis in oral squamous cell carcinoma by cDNA microarray analysis.
Nagata M; Fujita H; Ida H; Hoshina H; Inoue T; Seki Y; Ohnishi M; Ohyama T; Shingaki S; Kaji M; Saku T; Takagi R
Int J Cancer; 2003 Sep; 106(5):683-9. PubMed ID: 12866027
[TBL] [Abstract][Full Text] [Related]
31. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma.
Farley JH; Hickey KW; Carlson JW; Rose GS; Kost ER; Harrison TA
Cancer; 2003 May; 97(9):2196-202. PubMed ID: 12712471
[TBL] [Abstract][Full Text] [Related]
32. New approaches to pathogenic gene function discovery with human squamous cell cervical carcinoma by gene ontology.
Seo MJ; Bae SM; Kim YW; Kim YW; Hur SY; Ro DY; Lee JM; Namkoong SE; Kim CK; Ahn WS
Gynecol Oncol; 2005 Mar; 96(3):621-9. PubMed ID: 15721403
[TBL] [Abstract][Full Text] [Related]
33. Expression of MMP9 and CD147 in invasive squamous cell carcinoma of the uterine cervix and their implication.
Yu W; Liu J; Xiong X; Ai Y; Wang H
Pathol Res Pract; 2009; 205(10):709-15. PubMed ID: 19541433
[TBL] [Abstract][Full Text] [Related]
34. Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers.
Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
Gynecol Oncol; 2009 Jul; 114(1):84-8. PubMed ID: 19356789
[TBL] [Abstract][Full Text] [Related]
35. Molecular characterization of early adenocarcinoma of the uterine cervix by oligonucleotide microarray.
Liao LM; Zheng M; Huang L; Ding H; He L; Zhang Y; Wang HY
Arch Gynecol Obstet; 2011 Apr; 283(4):861-9. PubMed ID: 20496073
[TBL] [Abstract][Full Text] [Related]
36. The novel serine protease tumor-associated differentially expressed gene-15 (matriptase/MT-SP1) is highly overexpressed in cervical carcinoma.
Santin AD; Cane' S; Bellone S; Bignotti E; Palmieri M; De Las Casas LE; Anfossi S; Roman JJ; O'Brien T; Pecorelli S
Cancer; 2003 Nov; 98(9):1898-904. PubMed ID: 14584072
[TBL] [Abstract][Full Text] [Related]
37. N-cadherin and P-cadherin are biomarkers for invasion, metastasis, and poor prognosis of gallbladder carcinomas.
Yi S; Yang ZL; Miao X; Zou Q; Li J; Liang L; Zeng G; Chen S
Pathol Res Pract; 2014 Jun; 210(6):363-8. PubMed ID: 24636838
[TBL] [Abstract][Full Text] [Related]
38. CD109 expression in squamous cell carcinoma of the uterine cervix.
Zhang JM; Hashimoto M; Kawai K; Murakumo Y; Sato T; Ichihara M; Nakamura S; Takahashi M
Pathol Int; 2005 Apr; 55(4):165-9. PubMed ID: 15826242
[TBL] [Abstract][Full Text] [Related]
39. Target-based molecular signature characteristics of cervical adenocarcinoma and squamous cell carcinoma.
Kim YW; Bae SM; Kim YW; Park DC; Lee KH; Liu HB; Kim IW; Jang CK; Ahn WS
Int J Oncol; 2013 Aug; 43(2):539-47. PubMed ID: 23707988
[TBL] [Abstract][Full Text] [Related]
40. Identification and characterization of genes involved in the carcinogenesis of human squamous cell cervical carcinoma.
Cheng Q; Lau WM; Tay SK; Chew SH; Ho TH; Hui KM
Int J Cancer; 2002 Mar; 98(3):419-26. PubMed ID: 11920594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
